Acadia Healthcare Company, Inc. cash flow to debt ratio of 4.97% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Acadia Healthcare Company, Inc.'s free cash flow has increased -21.54% from $-560.69M last year to $-439.91M, signaling increasing performance

Acadia Healthcare Company, Inc.'s debt to equity ratio is 1.30, which means that the company's assets are unhealthy financed, signaling financial risk.

Acadia Healthcare Company, Inc.'s debt has increased relative to shareholder equity from 0.68 last year to 1.30 today, signaling weakened financials

Acadia Healthcare Company, Inc. has negative EBITDA, making leverage ratio unreliable

Acadia Healthcare Company, Inc.'s interest coverage ratio of 2.24 indicates that earnings with margin can cover interest payments on company debt

Acadia Healthcare Company, Inc.'s profit margin has decreased (512.65%) in the last year from 8.10% to -33.44%, signaling decreasing performance

Acadia Healthcare Company, Inc.'s short-term assets of $814.14M exceed its short-term liabilities of $525.19M

Acadia Healthcare Company, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Acadia Healthcare Company, Inc.'s return on equity of -50.02%, is lower than 15.00%, indicating bad performance

Acadia Healthcare Company, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Acadia Healthcare Company, Inc. had positive net income in 3 out of 5 years, indicating stable and consistent earnings

Acadia Healthcare Company, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Acadia Healthcare Company, Inc. has negative free cash flow, indicating cash burn

Acadia Healthcare Company, Inc.'s yearly earnings has decreased 531.42% since last year from $255.61M to $-1.10B, signaling decreasing performance

Acadia Healthcare Company, Inc.'s yearly revenue has increased 5.04% since last year from $3.15B to $3.31B, signaling increasing performance

ROIC 6.69% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Acadia Healthcare Company, Inc.'s 3-year revenue CAGR of 8.27% is positive, indicating growing revenue over the past 3 years

Acadia Healthcare Company, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Acadia Healthcare Company, Inc. had positive ROE in 3 out of 5 years, indicating consistent and reliable returns on equity

Acadia Healthcare Company, Inc. has insufficient data to evaluate this check.

Acadia Healthcare Company, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Acadia Healthcare Company, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Acadia Healthcare Company, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Acadia Healthcare Company, Inc. is undervalued relative to its fair value price of 131.84 based on Earnings Fair Value model

Acadia Healthcare Company, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Acadia Healthcare Company, Inc. has a price-to-book ratio of 1.32x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Acadia Healthcare Company, Inc. has a price-to-sales ratio of 0.86x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue